Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis

Osteoarthritis (OA), as a degenerative disease, leads to high socioeconomic burdens and disability rates. The knee joint is typically the most affected and is characterized by progressive destruction of articular cartilage, subchondral bone remodeling, osteophyte formation and synovial inflammation....

Full description

Bibliographic Details
Main Authors: Danni Luo, Hao Zhu, Song Li, Zhenggang Wang, Jun Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2024.1309946/full
_version_ 1797354468291903488
author Danni Luo
Hao Zhu
Song Li
Zhenggang Wang
Jun Xiao
author_facet Danni Luo
Hao Zhu
Song Li
Zhenggang Wang
Jun Xiao
author_sort Danni Luo
collection DOAJ
description Osteoarthritis (OA), as a degenerative disease, leads to high socioeconomic burdens and disability rates. The knee joint is typically the most affected and is characterized by progressive destruction of articular cartilage, subchondral bone remodeling, osteophyte formation and synovial inflammation. The current management of OA mainly focuses on symptomatic relief and does not help to slow down the advancement of disease. Recently, mesenchymal stem cells (MSCs) and their exosomes have garnered significant attention in regenerative therapy and tissue engineering areas. Preclinical studies have demonstrated that MSC-derived exosomes (MSC-Exos), as bioactive factor carriers, have promising results in cell-free therapy of OA. This study reviewed the application of various MSC-Exos for the OA treatment, along with exploring the potential underlying mechanisms. Moreover, current strategies and future perspectives for the utilization of engineered MSC-Exos, alongside their associated challenges, were also discussed.
first_indexed 2024-03-08T13:50:50Z
format Article
id doaj.art-fefdb52602c348dc8cf265cccb20efa8
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-03-08T13:50:50Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-fefdb52602c348dc8cf265cccb20efa82024-01-16T04:37:17ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852024-01-011210.3389/fbioe.2024.13099461309946Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritisDanni LuoHao ZhuSong LiZhenggang WangJun XiaoOsteoarthritis (OA), as a degenerative disease, leads to high socioeconomic burdens and disability rates. The knee joint is typically the most affected and is characterized by progressive destruction of articular cartilage, subchondral bone remodeling, osteophyte formation and synovial inflammation. The current management of OA mainly focuses on symptomatic relief and does not help to slow down the advancement of disease. Recently, mesenchymal stem cells (MSCs) and their exosomes have garnered significant attention in regenerative therapy and tissue engineering areas. Preclinical studies have demonstrated that MSC-derived exosomes (MSC-Exos), as bioactive factor carriers, have promising results in cell-free therapy of OA. This study reviewed the application of various MSC-Exos for the OA treatment, along with exploring the potential underlying mechanisms. Moreover, current strategies and future perspectives for the utilization of engineered MSC-Exos, alongside their associated challenges, were also discussed.https://www.frontiersin.org/articles/10.3389/fbioe.2024.1309946/fullexosomesosteoarthritismesenchymal stem cellstissue engineeringcartilage regeneration
spellingShingle Danni Luo
Hao Zhu
Song Li
Zhenggang Wang
Jun Xiao
Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
Frontiers in Bioengineering and Biotechnology
exosomes
osteoarthritis
mesenchymal stem cells
tissue engineering
cartilage regeneration
title Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
title_full Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
title_fullStr Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
title_full_unstemmed Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
title_short Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis
title_sort mesenchymal stem cell derived exosomes as a promising cell free therapy for knee osteoarthritis
topic exosomes
osteoarthritis
mesenchymal stem cells
tissue engineering
cartilage regeneration
url https://www.frontiersin.org/articles/10.3389/fbioe.2024.1309946/full
work_keys_str_mv AT danniluo mesenchymalstemcellderivedexosomesasapromisingcellfreetherapyforkneeosteoarthritis
AT haozhu mesenchymalstemcellderivedexosomesasapromisingcellfreetherapyforkneeosteoarthritis
AT songli mesenchymalstemcellderivedexosomesasapromisingcellfreetherapyforkneeosteoarthritis
AT zhenggangwang mesenchymalstemcellderivedexosomesasapromisingcellfreetherapyforkneeosteoarthritis
AT junxiao mesenchymalstemcellderivedexosomesasapromisingcellfreetherapyforkneeosteoarthritis